Skip to content

Smart Technology for Weight Loss and Metabolic Health

Smart Technology for Weight Loss and Metabolic Health- A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02742662
Enrollment
29
Registered
2016-04-19
Start date
2016-04-30
Completion date
2017-11-30
Last updated
2018-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lifestyle, Obesity, Overweight, Prediabetes, Weight Loss

Keywords

Obesity, Overweight, Prediabetes, Smartphone application, Technology, Weight Loss, Lifestyle Intervention

Brief summary

The study will evaluate whether a technology-based lifestyle intervention program using primarily a smartphone platform is an acceptable and effective way for treating obesity. The goal of the program is to achieve weight loss and enhance the health of overweight or obese subjects by improving their diet and activity via smartphone applications as compared with conventional in-person weight management programs.

Interventions

DEVICEWearable technology, smartscale
BEHAVIORALStandard Weight Management Visits

Sponsors

The Obesity Treatment Foundation
CollaboratorUNKNOWN
Temple University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Overweight or obese BMI 25-42 kg/m2 * Employed in sedentary occupations * Own a personal smartphone with unlimited data plan or \>4 GigaByte data * Proficient with use of smartphone applications and technology with current daily usage * Ability to engage in moderate intensity exercise * Weight stability for the last 2 months * Participants must be willing to comply with all study-related procedures

Exclusion criteria

* Current or planned pregnancy * Cardiovascular, pulmonary, renal disease, joint disease * Uncontrolled thyroid disease * History of eating disorders, psychiatric disease * History of substance abuse or dependence in the last 1 year * Diabetes * Shift work * Previous weight loss surgery * Use of weight loss drugs/diet/program in the last 6 weeks * Inability to increase walking as a form of exercise and to engage in moderate intensity exercise * Other conditions or medications that affect body weight/appetite/metabolism * Serious or unstable medical or psychological conditions that would compromise the subject's safety for successful participation * Incapable of adhering with an intensive lifestyle intervention using technology and smartphone applications

Design outcomes

Primary

MeasureTime frame
Change in body weight in kg6 months

Secondary

MeasureTime frameDescription
Change from baseline waist circumference6 months
Change from baseline insulin resistance by homeostasis model assessment (HOMA-IR)6 months
Change from baseline hemoglobin A1c6 months
Change from baseline plasma triglycerides6 months
Change from baseline blood pressure6 months
Change in Quality of Life6 months after receiving the interventionSF36 Questionnaire in wait-listed control group after the intervention
Change in insulin resistance by homeostasis model assessment (HOMA-IR)12 months compared to baseline and 6 months after receiving the interventionWait-listed control group
Change in hemoglobin A1c12 months compared to baseline and 6 months after receiving the intervention and from baselineWait-listed control group
Change in plasma triglycerides12 months compared to baseline and 6 months after receiving the interventionWait-listed control group
Change from baseline body weight in kg3 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026